	Bellmunt Risk Score as a Prognostic Tool in Metastatic Castration-Resistant Prostate Cancer Survival. JAMA Netw Open Büttner T, Klümper N, Ellinger J, Ritter M, Krausewitz P. PMID: 41790469 [PubMed - in process]
	Fatty Breasts and Palpable Lumps: Diagnostic Mammogram Alone May Be Sufficient to Exclude Cancer. J Breast Imaging Nwamuo DC, Lin GH, Gillon S, Lydon CM, Leimpeter A, Shan J, Habel LA, Achacoso NS, Westley M, Xu T, Mak D, Lee C, Wisner D, Arasu VA. PMID: 41790460 [PubMed - as supplied by publisher]
	FDA Approval Summary: Pembrolizumab for the Treatment of HER2-Positive Gastric Cancer. Clin Cancer Res Casak SJ, Zhang Y, Song C, Mishra-Kalyani PS, Tang S, Auth D, de Claro RA, Pazdur R, Lemery SJ. PMID: 41790455 [PubMed - as supplied by publisher]
	Iron, inflammation, and intestinal tumors: the crucial triad in colorectal cancer progression and therapy. Clin Transl Oncol Abediasl M, Siavash M, Esfahani SS, Amini Z, Amiri K, Saket S, Esmaeili E, Rafizadeh F, Saraei R, Fakhr MS. PMID: 41790430 [PubMed - as supplied by publisher]
	HLA-E as an Emerging Checkpoint and BiomarkerÂ in Personalized Cancer Immunotherapy. Curr Med Sci Sanmugawil R, Parmeswaran L, Abdul Rahman N, Hassan N. PMID: 41790393 [PubMed - as supplied by publisher]
	The Intricate Dance Between Inflammation and Myeloproliferative Neoplasms: From Origins to Outcomes. Curr Hematol Malig Rep Fleischman AG. PMID: 41790379 [PubMed - in process]
	MYELOstudy: lymph node stage of aggressiveness in medullary thyroid cancer-a retrospective multi-center study analysis. Updates Surg Papavramidis T, Chorti A, Bakkar S, Raffaelli M, Ko, Hoang VT, Lim JY, Genc V, Minuto MN, Calò PG, Hellmann A, Di Filippo G, Karakozis L, Chrisoulidou A, Gamgaram VKD, Sriphrapradang C, Leclère JC, Orois A, Marco D, Dhiwakar M, de Pasquale L, Buemi A, Nesti C, Pandev R, Chala A, Yal, Hajiioannou J, Liu SY, Cherenko S, Voloudakis N, Koutelidakis I, Nastos K, Constanza R, Dobrinja C, Brunner M, Bains L, Panchangam RB, Girardi FM, Arikan AE, El Malki HO, de Cillia M, Oragano L, Pliakos I, Moysidis M, Pennestrì F, De Crea C, , Tarle A, Senashova OS, Shindo ML, Tüzken , Turhan MA, Varaldo E, Albertelli M, Medas F, Canu GL, Cappellacci F, , Lazzari G, Morelli E, Karakozis S, Boudina M, Katsamakas M, Guevara MI, Aroonroch R, Manyalich M, Vidal O, Triponez F, Masse N, Kathirvel L, Muthusamy R, La Rubia P, Castellani L, Maria-Cristina B, Raluca-Maria F, Kaderli R, Teksoz S, Chow TC, Lai MS, Shchekaturova L, Bellou E, Banus M, Da Milano R, Mastronardi M, Grützmann R, Hauth LA, Abentroth AL, Dulgeroglu O, Uras C, Placentino G, Leutner M. PMID: 41790369 [PubMed - as supplied by publisher]
	Serum Exosomal Hsa_circ_0005692 as A Novel Biomarker for Colorectal Cancer Metastasis: A Retrospective Observational Study. Appl Biochem Biotechnol Zhang J, Han Z, Han Y, Xing X, Xu M. PMID: 41790367 [PubMed - as supplied by publisher]
	Multi-omics analysis suggests ZDHHC18 as a potential risk factor for clear cell renal cell carcinoma linked to myeloid DC morphology. Discov Oncol Guo A, Lu Y, Wang J, Jia Z, Yang J, Ning X. PMID: 41790354 [PubMed - as supplied by publisher]
	Does the management of anastomotic leakage after rectal cancer resection affect long-term oncological survival? A retrospective propensity score-adjusted cohort study. Tech Coloproctol Ammann Y, Marti L, Warschkow R, Bischofberger S, Reißfelder C, Schmied B, Brunner W, Tarantino I. PMID: 41790293 [PubMed - in process]
	Placebo treatments for cancer related fatigue: a reply to Jacobs et al. 2026. Support Care Cancer Fontaine KR, Hoenemeyer T, Kaptchuk T. PMID: 41790291 [PubMed - in process]
	Status and influencing factors of resilience among patients with lung cancer undergoing chemotherapy: a qualitative study. Support Care Cancer Xu T, Lu H, Xiao W, Liao J, Gu D. PMID: 41790266 [PubMed - in process]
	Assessment of radiotherapy effect and toxicity using tissue-associated DNA methylation markers in cell-free DNA: a study on prostate cancer. Radiat Environ Biophys Bahtiyar N, Mermut O, Firtina S, Ozaydin A, Suleymanova A, Isikgil B, Onaran . PMID: 41790195 [PubMed - as supplied by publisher]
	A two-sample Mendelian randomization study of the causal relationship between respiratory diseases, gastric cancer risk, and Helicobacter pylori infection. Gastric Cancer Kim Y, Lee S, Lee J, Park MY, Min J, Ma X, Sumikawa MH, Yoon JH, Lee W. PMID: 41790153 [PubMed - as supplied by publisher]
	ELIOS: A Multicenter, Molecular Profiling Study of Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer Treated with First-Line Osimertinib. Cancer Discov Piotrowska Z, Ahn MJ, Voon PJ, Pang YK, How SH, Kim SW, Cortinovis D, de Castro Carpeño J, Tiseo M, Rodríguez Abreu D, Ramalingam SS, Li J, Servidio L, Taylor R, Hartmaier R, Markovets AA, Tang KH, Cho BC. PMID: 41790042 [PubMed - as supplied by publisher]
	The KRAS-variant and cetuximab in HPV-positive oropharyngeal cancer - results from the NRG/RTOG 1016 trial. Cancer Res Commun Weidhaas JB, Harris J, Gillison ML, Blakaj D, Krempl GA, Higgins K, Phan J, Dunlap NE, Mahamood ST, Dorth J, Caudell JJ, Desai AB, Galloway TJ, Pennington JD, Currey A, Lathrop J, Torres-Saavedra PA, Hayes DN, Yom SS, Le QT. PMID: 41790036 [PubMed - as supplied by publisher]
	Genomic Profiling of Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer Post-Progression on First-Line Osimertinib: Phase II ORCHARD Study. Clin Cancer Res Yu HA, Tang KH, Markovets AA, Hartmaier R, Smith PE, Cho BC, De Langen AJ, Goldberg SB, Goldman JW, Le X, Iwama E, Cosaert J, Riess JW, Piotrowska Z. PMID: 41790029 [PubMed - as supplied by publisher]
	Preoperative Contrast-enhanced CT Features Associated with Occult Lymph Node Metastasis in Early-Stage Solid Non-Small Cell Lung Cancer. Radiol Imaging Cancer Feng Y, Zhang H, Yu J, Wang L, Wu Y, Zhu L, Zheng J, Chen Y, Lai J, Yang H, Tung TH, Cai M, Ji W. PMID: 41790023 [PubMed - in process]
	TACE with Lenvatinib and Pembrolizumab in Unresectable, Nonmetastatic Hepatocellular Carcinoma: Results from the LEAP-012 Trial. Radiol Imaging Cancer Siddiqi NS. PMID: 41790022 [PubMed - in process]
	Artificial Intelligence Meets Cancer Rehabilitation: Emerging Evidence for Exercise and Physical Activity Interventions. Cancer Control Bland KA, Catalá-Vilaplana I, Nunez JJ, Capozzi LC, Campbell KL. PMID: 41789982 [PubMed - in process]

Articles 1 - 20 / 1914500

Page 1 of 95725



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy